spacer
home > pmps > summer 2002 > options in materials for liquid-filled capsules
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Options in Materials for Liquid-Filled Capsules

This article describes the current status of some potential substitutes for gelatine two-piece capsules, with particular reference to their suitability for liquid products. Animal gelatine presents a number of issues, including technical, regulatory, commercial and consumer acceptability aspects. The use of possible substitutes - 'fish gelatine', starch and hydroxypropyl methylcellulose (HPMC) - is discussed. Particular reference is made to progress in the suitability of HPMC capsules for commercial manufacture (including filling and sealing). The article will also include relevant comment on their current regulatory status.

Hard (or 'two-piece') capsules have been used in medicines for many years, and are also being used in increasing quantities in nutraceuticals. The commercial manufacturing process for the capsule shell itself was first established for gelatine in 1913. It led to the development of major automatic machines which form the basis of current shell manufacture worldwide.

The raw material gelatine, however, is derived from animal material and has presented a wide range of issues (technical, regulatory, commercial, limits to consumer selection according to religious or dietary needs) and there have been many investigations and commercial efforts to identify possible substitutes (1). In recent years, safety concerns about transmissible spongiform encephalopathies (TSE) and other animal diseases have increased the need for such materials. This paper describes the current status of a) gelatine derived from fish, b) starch and c) hydroxypropyl methylcellulose (HPMC) as potential substitutes for current gelatine two-piece capsules, including assessment of their suitability for liquid products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By William Bowtle, Technical Director at MW Encap Ltd, UK William Bowtle, Technical Director at MW Encap, is one of the leading scientists in liquid filling of hard gelatine capsules. After graduating with a first class honours degree in Pharmacy from Strathclyde University in Glasgow, Scotland, he continued his research work while assuming the post of Lecturer in Pharmaceutics, and was awarded a Pfizer Research Prize.
He later moved into industry and worked for 13 years with Eli Lilly, where, as Head of Pharmaceutical Development, he was responsible for the development of a range of oral and parenteral products for international markets. During that time he developed the 'semi-solid matrix' capsule technology. In his position as Technical Director at MW Encap, Bill is responsible for the co-ordination of all technical aspects of new products.

spacer
William Bowtle
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement